These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 14569544)

  • 1. Perianesthesia care of the patient with gastroesophageal reflux disease.
    Redmond MC
    J Perianesth Nurs; 2003 Oct; 18(5):335-44; quiz 345-7. PubMed ID: 14569544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric gastroesophageal reflux disease.
    Blanco FC; Davenport KP; Kane TD
    Surg Clin North Am; 2012 Jun; 92(3):541-58, viii. PubMed ID: 22595708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: approaches to the long-term management of adults with GERD-proton pump inhibitor therapy, laparoscopic fundoplication or endoscopic therapy?
    Freston JW; Triadafilopoulos G
    Aliment Pharmacol Ther; 2004 Feb; 19 Suppl 1():35-42. PubMed ID: 14725577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Surgery of the hiatal hernia and gastroesophageal reflux dinase, Nissen or Toupet?].
    Kasalický M; Koblihová E
    Rozhl Chir; 2015 Dec; 94(12):510-5. PubMed ID: 26767901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of supraesophageal complications of gastroesophageal reflux disease in infants and children.
    Orenstein SR
    Am J Med; 2000 Mar; 108 Suppl 4a():139S-143S. PubMed ID: 10718467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do patients with gastroesophageal reflux disease and somatoform tendencies benefit from antireflux surgery?
    Fuchs HF; Babic B; Fuchs KH; Breithaupt W; Varga G; Musial F
    World J Gastroenterol; 2019 Jan; 25(3):388-397. PubMed ID: 30686906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of laparoscopic fundoplication in relieving the symptoms of gastroesophageal reflux disease (GERD) and eliminating antireflux medical therapy.
    Papasavas PK; Keenan RJ; Yeaney WW; Caushaj PF; Gagné DJ; Landreneau RJ
    Surg Endosc; 2003 Aug; 17(8):1200-5. PubMed ID: 12739117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Goals of therapy and guidelines for treatment success in symptomatic gastroesophageal reflux disease patients.
    Bytzer P
    Am J Gastroenterol; 2003 Mar; 98(3 Suppl):S31-9. PubMed ID: 12644029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastroesophageal reflux disease: could intervention in childhood reduce the risk of later complications?
    Gold BD
    Am J Med; 2004 Sep; 117 Suppl 5A():23S-29S. PubMed ID: 15478849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Evidence-Based Approach to the Treatment of Gastroesophageal Reflux Disease.
    Patti MG
    JAMA Surg; 2016 Jan; 151(1):73-8. PubMed ID: 26629969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current management of gastroesophageal reflux disease.
    DeVault KR
    Gastroenterologist; 1996 Mar; 4(1):24-32. PubMed ID: 8689142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical management of gastroesophageal reflux disease in patients with systemic sclerosis.
    Yan J; Strong AT; Sharma G; Gabbard S; Thota P; Rodriguez J; Kroh M
    Surg Endosc; 2018 Sep; 32(9):3855-3860. PubMed ID: 29435755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.
    Stefanidis G; Viazis N; Kotsikoros N; Tsoukalas N; Lala E; Theocharis L; Fassaris A; Manolakopoulos S
    Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27868281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of surgical approaches to recalcitrant gastroesophageal reflux disease in the patient with scleroderma.
    Kent MS; Luketich JD; Irshad K; Awais O; Alvelo-Rivera M; Churilla P; Fernando HC; Landreneau RJ
    Ann Thorac Surg; 2007 Nov; 84(5):1710-5; discussion 1715-6. PubMed ID: 17954091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of obesity treatment on gastroesophageal reflux disease.
    Khan A; Kim A; Sanossian C; Francois F
    World J Gastroenterol; 2016 Jan; 22(4):1627-38. PubMed ID: 26819528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoluminal Therapy for Gastroesophageal Reflux Disease: In Between the Pill and the Knife?
    Brar TS; Draganov PV; Yang D
    Dig Dis Sci; 2017 Jan; 62(1):16-25. PubMed ID: 27796767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors that influence therapeutic outcomes in symptomatic gastroesophageal reflux disease.
    Quigley EM
    Am J Gastroenterol; 2003 Mar; 98(3 Suppl):S24-30. PubMed ID: 12644028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of endoscopic fundoplication and proton pump inhibitors on baseline impedance and heartburn severity in GERD patients.
    Rinsma NF; Farré R; Bouvy ND; Masclee AA; Conchillo JM
    Neurogastroenterol Motil; 2015 Feb; 27(2):220-8. PubMed ID: 25348594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic fundoplication for the treatment of gastroesophageal reflux disease: initial experience.
    Narsule CK; Burch MA; Ebright MI; Hess DT; Rivas R; Daly BD; Fernando HC
    J Thorac Cardiovasc Surg; 2012 Jan; 143(1):228-34. PubMed ID: 22070927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradigm shift in the management of gastroesophageal reflux disease.
    Richards WO; Houston HL; Torquati A; Khaitan L; Holzman MD; Sharp KW
    Ann Surg; 2003 May; 237(5):638-47; discussion 648-9. PubMed ID: 12724630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.